These are complex medicines made, as I said, from living cells that treat cancer, autoimmune diseases and rare disorders that affect millions of Americans. Biologics make up only 5% of our prescription, but they account for more than half of our drug spending. Between 2013 and 2021. Our spending on biologics more than doubled 100 billion to 260 billion. By 2024, it reached 407 billion. Some biologics cost patients up to a half million dollars a year or even more. (03:36–03:44)
CLAIM
Asserts that biologics constitute a small percentage of prescriptions but a large portion of drug spending.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.
